Schonfeld Strategic Advisors LLC Astrazeneca PLC Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 23,360 shares of AZN stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,360
Previous 36,300
35.65%
Holding current value
$1.76 Million
Previous $2.38 Million
27.84%
% of portfolio
0.01%
Previous 0.02%
Shares
24 transactions
Others Institutions Holding AZN
# of Institutions
1,413Shares Held
506MCall Options Held
9.17MPut Options Held
3.07M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...